While there is a big buzz around digital adoption by Indian Pharma, necessitated by the disruption brought about by Covid-19, it is also a good time to discuss the future of Indian Pharma market and how it is likely to shape up. This article by Rajeev Kumar was published in…
It is well accepted that pharma field force access to doctors has been decreasing over the years. However, face to face interactions are preferred whenever the doctors think that they add value. The question then becomes one of how to define value. While different doctors will value different things, this…
How should healthcare business leaders (pharma, devices, diagnostics, disposables and other related healthcare service providers to doctors and hospitals) respond to the challenges created by the Covid-19 pandemic? Covid-19 pandemic has created a two-fold challenge for medical doctors and healthcare workers. On one hand, those who are in the forefront…
This is the third and final part of MedicinMan interview with Sunil Attavar, CMD, Group Pharma and President, KDPMA MedicinMan: Are there any estimates of what the overall business impact will be in terms of revenues of pharma companies? At this moment it is very difficult to estimate the impact…
We will need to find a way to bring together the capabilities of the Medical Rep, the changed scenario of the visit and the ways we can reach doctors into one single strategy rather than looking at the physical and the digital parts separately. Our medical reps will continue to be the core of our promotion, and our digital strategy will need to empower them to not only do a better call but also support their efforts by building processes that will help them beyond the few minutes that they spend in the Clinic. Marketing budgets will have to move away from conventional investments and also think beyond hardware to increase digital engagement.
This is the first part of MedicinMan interview series with pharma business leaders to make sense of the Covid19 crisis and its impact on healthcare industry. Subscribe to MedicinMan to get regular updates of interactions with pharma business leaders. MedicinMan: Give our readers, a sense of what is happening in the…
The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.
Raja Reddy is presently the head of marketing at Servier India. His distinguished career began as a Medical Rep and progressed to Regional Manager and Product Manager, on to his current role. Raja, prefers to describe himself as a tinkerer, observer and eternal seeker. He is a graduate in life sciences,…
For a person wanting to be a doctor, my entire career revolved around the medical fraternity. Having failed to get admission into MBBS, by a few marks, I pursued my graduation and post-graduation even though I got a seat for BDS, as dentistry was not my choice, back in the…
Interview with Hanno Wolfram, author of Digital in Health Anup Soans: Tell us something about your journey in the world of health care and your significant career milestones. Hanno Wolfram: About half of my professional life, I spent inside the pharmaceutical industry. Like many others, my career began in a research-based…